Harvard Bioscience Inc (HBIO)
2.36
-0.04
(-1.67%)
USD |
NASDAQ |
Nov 04, 16:00
2.365
0.00 (0.00%)
After-Hours: 20:00
Harvard Bioscience Profit Margin (Quarterly): -12.67% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -12.67% |
| March 31, 2024 | -19.15% |
| December 31, 2023 | -6.46% |
| September 30, 2023 | -4.89% |
| June 30, 2023 | -3.41% |
| March 31, 2023 | 2.08% |
| December 31, 2022 | -5.86% |
| September 30, 2022 | -12.65% |
| June 30, 2022 | 8.34% |
| March 31, 2022 | -23.91% |
| December 31, 2021 | 2.91% |
| September 30, 2021 | -0.57% |
| June 30, 2021 | -1.40% |
| March 31, 2021 | -2.48% |
| December 31, 2020 | -1.98% |
| September 30, 2020 | -4.57% |
| June 30, 2020 | -6.78% |
| March 31, 2020 | -19.00% |
| December 31, 2019 | 1.78% |
| September 30, 2019 | -9.56% |
| June 30, 2019 | -0.83% |
| March 31, 2019 | -8.40% |
| December 31, 2018 | 8.45% |
| September 30, 2018 | -0.89% |
| June 30, 2018 | -4.64% |
| Date | Value |
|---|---|
| March 31, 2018 | -15.19% |
| December 31, 2017 | 4.62% |
| September 30, 2017 | -2.23% |
| June 30, 2017 | -2.01% |
| March 31, 2017 | -5.89% |
| December 31, 2016 | -5.00% |
| September 30, 2016 | -6.55% |
| June 30, 2016 | -2.73% |
| March 31, 2016 | -2.36% |
| December 31, 2015 | -60.42% |
| September 30, 2015 | -3.29% |
| June 30, 2015 | 1.21% |
| March 31, 2015 | -5.44% |
| December 31, 2014 | -0.06% |
| September 30, 2014 | 2.49% |
| June 30, 2014 | 3.79% |
| March 31, 2014 | 2.78% |
| December 31, 2013 | -2.71% |
| September 30, 2013 | -3.91% |
| June 30, 2013 | -0.71% |
| March 31, 2013 | 0.37% |
| December 31, 2012 | 4.26% |
| September 30, 2012 | -0.51% |
| June 30, 2012 | 2.72% |
| March 31, 2012 | 1.87% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-23.91%
Minimum
Mar 2022
8.34%
Maximum
Jun 2022
-5.83%
Average
-4.57%
Median
Sep 2020
Profit Margin (Quarterly) Benchmarks
| Bruker Corp | 0.95% |
| Azenta Inc | -3.81% |
| Bionano Genomics Inc | -208.8% |
| Akoya Biosciences Inc | -56.76% |
| Singular Genomics Systems Inc | -2.88K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -14.88% |
| Return on Assets | -7.83% |
| Return on Invested Capital | -9.76% |
| Gross Profit Margin (Quarterly) | 57.23% |
| Operating Margin (Quarterly) | -7.88% |
| Return on Net Operating Assets | -8.77% |